Brian Abrahams
Stock Analyst at RBC Capital
(4.82)
# 458
Out of 4,516 analysts
1773
Total ratings
56.3%
Success rate
15.4%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Buy | $242 | $195.34 | +23.89% | 199 | Jul 14, 2026 | |
| KYMR Kymera Therapeutics | Downgraded: Hold | $106 → $115 | $112.83 | +1.92% | 7 | Jul 13, 2026 | |
| NMRA Neumora Therapeutics | Maintained: Buy | $7 → $5 | $1.63 | +207.69% | 21 | Jul 13, 2026 | |
| NRIX Nurix Therapeutics | Rated: Buy | $30 → $33 | $23.61 | +39.77% | 10 | Jul 9, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $29 → $36 | $25.95 | +38.73% | 14 | Jul 7, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $13 → $14 | $9.42 | +48.62% | 99 | Jul 7, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $122 → $120 | $132.34 | -9.32% | 211 | Jul 7, 2026 | |
| INCY Incyte | Maintained: Hold | $95 → $99 | $115.50 | -14.29% | 136 | Jul 7, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $183 → $195 | $172.27 | +13.19% | 92 | Jul 7, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $707 → $696 | $664.00 | +4.82% | 81 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $543 → $570 | $479.22 | +18.94% | 150 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $17.31 | +9.76% | 135 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 → $85 | $78.40 | +8.43% | 100 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.59 | +66.84% | 106 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $30.63 | +30.59% | 3 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $30 | $12.15 | +146.91% | 5 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $97 → $135 | $134.20 | +0.60% | 8 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $57 | $45.50 | +25.27% | 20 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $36 | $8.88 | +305.41% | 31 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.5299 | +88.71% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $26.86 | +48.92% | 9 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $29.46 | -4.96% | 58 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $24 → $23 | $43.09 | -46.62% | 6 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $1.12 | +79.37% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $16 | $19.35 | -17.31% | 10 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $8.56 | +51.87% | 26 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $82 | $67.53 | +21.43% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $6.12 | -1.96% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $14.17 | +55.26% | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39.00 | $52.81 | -26.15% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $13.08 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $288 | $12.78 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8 | $5.43 | n/a | 7 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $2.49 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $358.22 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $7.23 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $179.80 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $31.54 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $143.01 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $48.99 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $80.78 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $6.33 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $40.45 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $15.40 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $76.87 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $38.30 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $23.55 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $35.90 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $106.89 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $58.96 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $31.74 | n/a | 1 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $246.84 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $58.45 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.91 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,144.18 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $250.81 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $123.75 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $24.74 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.85 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $151.51 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $41.50 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.33 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $8.30 | n/a | 1 | Sep 2, 2009 |
Biogen
Jul 14, 2026
Maintained: Buy
Price Target: $242
Current: $195.34
Upside: +23.89%
Kymera Therapeutics
Jul 13, 2026
Downgraded: Hold
Price Target: $106 → $115
Current: $112.83
Upside: +1.92%
Neumora Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $7 → $5
Current: $1.63
Upside: +207.69%
Nurix Therapeutics
Jul 9, 2026
Rated: Buy
Price Target: $30 → $33
Current: $23.61
Upside: +39.77%
ACADIA Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $29 → $36
Current: $25.95
Upside: +38.73%
BioCryst Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: $13 → $14
Current: $9.42
Upside: +48.62%
Gilead Sciences
Jul 7, 2026
Maintained: Hold
Price Target: $122 → $120
Current: $132.34
Upside: -9.32%
Incyte
Jul 7, 2026
Maintained: Hold
Price Target: $95 → $99
Current: $115.50
Upside: -14.29%
Neurocrine Biosciences
Jul 7, 2026
Maintained: Buy
Price Target: $183 → $195
Current: $172.27
Upside: +13.19%
Regeneron Pharmaceuticals
Jul 7, 2026
Maintained: Hold
Price Target: $707 → $696
Current: $664.00
Upside: +4.82%
Jul 7, 2026
Maintained: Buy
Price Target: $543 → $570
Current: $479.22
Upside: +18.94%
Jul 7, 2026
Maintained: Hold
Price Target: $19
Current: $17.31
Upside: +9.76%
Jul 7, 2026
Maintained: Hold
Price Target: $82 → $85
Current: $78.40
Upside: +8.43%
Jul 7, 2026
Maintained: Buy
Price Target: $16
Current: $9.59
Upside: +66.84%
Jun 30, 2026
Maintained: Buy
Price Target: $40
Current: $30.63
Upside: +30.59%
Jun 29, 2026
Maintained: Buy
Price Target: $50 → $30
Current: $12.15
Upside: +146.91%
Jun 23, 2026
Maintained: Hold
Price Target: $97 → $135
Current: $134.20
Upside: +0.60%
Jun 22, 2026
Maintained: Buy
Price Target: $36 → $57
Current: $45.50
Upside: +25.27%
May 26, 2026
Maintained: Buy
Price Target: $51 → $36
Current: $8.88
Upside: +305.41%
May 15, 2026
Maintained: Hold
Price Target: $1
Current: $0.5299
Upside: +88.71%
May 14, 2026
Maintained: Buy
Price Target: $40
Current: $26.86
Upside: +48.92%
May 13, 2026
Maintained: Hold
Price Target: $28
Current: $29.46
Upside: -4.96%
May 12, 2026
Maintained: Sell
Price Target: $24 → $23
Current: $43.09
Upside: -46.62%
May 11, 2026
Maintained: Hold
Price Target: $2
Current: $1.12
Upside: +79.37%
May 11, 2026
Maintained: Hold
Price Target: $13 → $16
Current: $19.35
Upside: -17.31%
May 8, 2026
Maintained: Hold
Price Target: $12 → $13
Current: $8.56
Upside: +51.87%
May 7, 2026
Maintained: Buy
Price Target: $80 → $82
Current: $67.53
Upside: +21.43%
May 7, 2026
Maintained: Hold
Price Target: $6
Current: $6.12
Upside: -1.96%
May 5, 2026
Maintained: Buy
Price Target: $22
Current: $14.17
Upside: +55.26%
Oct 26, 2025
Maintained: Buy
Price Target: $39.00
Current: $52.81
Upside: -26.15%
Oct 2, 2023
Maintained: Hold
Price Target: $25 → $15
Current: $13.08
Upside: n/a
Oct 28, 2022
Maintained: Hold
Price Target: $288
Current: $12.78
Upside: n/a
May 16, 2022
Maintained: Hold
Price Target: $9 → $8
Current: $5.43
Upside: n/a
Aug 16, 2021
Maintained: Hold
Price Target: $4
Current: $2.49
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $358.22
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $7.23
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $179.80
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $31.54
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $143.01
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $48.99
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $80.78
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $6.33
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $40.45
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $15.40
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $76.87
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $38.30
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $23.55
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $35.90
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $106.89
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $58.96
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $31.74
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $246.84
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $58.45
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $4.91
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,144.18
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $250.81
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $123.75
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $24.74
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $2.85
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $151.51
Upside: n/a
Feb 23, 2015
Maintained: Hold
Price Target: n/a
Current: $41.50
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.33
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $8.30
Upside: n/a